Publication of List of Manufacturers Granted Licence for the Manufacture of Therapeutic Goods

Overview

The Therapeutic Goods Act 1989 was enacted to regulate the importation, supply, and manufacturing of therapeutic goods in Australia, ensuring that these goods meet safety, quality, and efficacy standards. The Act addresses the need to protect public health by controlling the quality and safety of therapeutic goods, which include medicines, medical devices, and other related products. The Therapeutic Goods Administration, operating under the auspices of the Department of Health, is the body responsible for administering this Act. The overarching policy objective of the Therapeutic Goods Act 1989 is to safeguard the health and safety of the Australian public by ensuring that therapeutic goods available in the market are of acceptable quality and are used safely. This legislation thus provides a comprehensive framework for the regulation and oversight of therapeutic goods throughout their lifecycle, from manufacture to distribution and use.

Scope and Application

The Therapeutic Goods Act 1989 applies to a broad range of entities, including individuals, businesses, and organisations involved in the manufacture, supply, importation, exportation, or advertisement of therapeutic goods in Australia. The Act ensures the safety, quality, and efficacy of therapeutic goods, including medicines, medical devices, blood, and tissues, and it is enforced by the Therapeutic Goods Administration (TGA). The Act's jurisdictional reach is national, as it is a Commonwealth Act, applying uniformly across Australia, but it can also interact with state and territory laws in areas of concurrent jurisdiction. The publication of the list of manufacturers granted a licence, as per Section 38 of the Act, serves to publicly disclose entities authorised to manufacture therapeutic goods, enhancing transparency and accountability within the sector. The Act may extend or restrict its application through subordinate instruments, which provide detailed regulatory requirements and standards for different types of therapeutic goods. Exclusions or exemptions from the Act are specific to certain goods or activities as outlined in the legislation and its subsidiary regulations.

Key Provisions

The key provisions of the Therapeutic Goods Act 1989, as highlighted in the notice, involve the granting of a Licence to Manufacture Therapeutic Goods. Under Section 38 of the Act, the Secretary has the authority to grant such a licence (Section 38). This particular licence has been granted to the Department of Economic Development Jobs Transport and Resources, with the specific licence number MI-2016-LI-09655-1. The location of the manufacturing facility is also provided, being at 5 Ring Road, Bundoora, VIC, 3083. This licence permits the holder to manufacture therapeutic goods, which can include medicines, medical devices, and other related products, subject to compliance with the conditions and standards set by the Therapeutic Goods Administration. The obligations imposed on the parties governed by this Act include adherence to stringent manufacturing standards and processes. The licence holder must ensure that the therapeutic goods produced meet the required quality and safety standards as specified by the Therapeutic Goods Administration. This includes maintaining proper records, implementing quality control systems, and complying with good manufacturing practices (GMP). The holder must also ensure that all therapeutic goods are manufactured in accordance with approved product specifications and that any changes to the manufacturing process are notified to and approved by the Therapeutic Goods Administration. Failure to comply with the requirements set forth in the Therapeutic Goods Act 1989 can result in significant legal consequences. Breaches of the Act may lead to the imposition of both civil and criminal penalties. For instance, if the manufacturing process does not adhere to the required standards, the licence may be suspended or revoked. In more severe cases, individuals or entities may face fines, imprisonment, or both. The maximum penalties for certain offences can include fines of up to $1.1 million for corporations and $220,000 for individuals, alongside potential imprisonment terms. The specific penalties depend on the nature and severity of the breach, as outlined in the relevant sections of the Act.